Logo

23andMe

23andMe Stock Soars 22 Percent on Closing of Merger With VG Acquisition Corp

The company's official acquisition by the Virgin Group's special purpose acquisition company signaled its first day as a publicly traded entity on the Nasdaq.

In Brief This Week: Bio-Rad, 10x Genomics, IsoPlexis, 23andMe, PerkinElmer, LifeBit Biotech, More

News items for the week of May 24, 2021.

23andMe Begins Reporting PGx Variants With Drug Info Under Recent FDA Clearance
Premium

The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant.

23andMe Team Sees Genetic, Nongenetic Contributors to COVID-19 Risk in Trans-Ancestry Study

The researchers linked two genetic loci to disease susceptibility or severity, although socioeconomic levels and ancestry influenced hospitalizations, as well.

Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster
Premium

As the life science industry left 2020 behind, it joined a new trend: going public through a mechanism that combines an IPO and merger in one transaction.

Feb 4, 2021

23andMe to Go Public Through Merger With Virgin Group Acquisition Firm

Jan 21, 2021

Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics
Premium

Dec 29, 2020

23andMe Raises $82.5M in Private Financing

Nov 12, 2020

OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises

Aug 28, 2020

Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs
Premium

Aug 18, 2020

23andMe Garners FDA Clearance for CYP2C19 PGx Test Report

Aug 3, 2020

Ancestry Rolls Out Sequencing-Based Health Offering Focused on Common Conditions
Premium

Jul 23, 2020

Genetic Study Validates, Expands History of Transatlantic Slave Trade
Premium

Jun 15, 2020

U of Edinburgh Study to Use Consumer Genomics Data to Determine COVID-19 Genetic Risk

Apr 24, 2020

Ancestry to Make Consumer Genomics Database Available for COVID-19 Research Project

Apr 23, 2020

Finland's Negen Introduces Pharmacogenomics Panel for COVID-19 Therapies

Apr 8, 2020

23andMe to Study Genetic Factors of COVID-19 Severity Using Data From Consented Customers

Mar 30, 2020

Refractive Error GWAS Leads To More Than 300 New Loci

Mar 6, 2020

As Consumer Genomics Market Cools, Providers Ponder Better Ways to Reach Customers
Premium

Feb 6, 2020

Ancestry Lays off 6 Percent of Employees due to Consumer Slump

Jan 31, 2020

Translational Software to Submit PGx Software Platform for 510(k) Clearance
Premium

Jan 23, 2020

23andMe Lays off 100 Employees Across Consumer Business

Jan 9, 2020

Forensic Genomics Market Advances Due to Consumer Databases, Technology Innovation
Premium

Dec 10, 2019

Celmatix Sues 23andMe for $100M Alleging Breach of Contract

Oct 10, 2019

Uniparental Disomy More Common in General Population Than Previously Thought

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.